| 2025 | 2024 | |||
|---|---|---|---|---|
| Gross margin | -7,3 k € | +55.2% | -16,3 k € | |
| EBITDA | -7,3 k € | +55.2% | -16,3 k € | |
| Operating profit | -7,3 k € | +55.2% | -16,3 k € | |
| Profit/loss | -7,5 k € | +54.1% | -16,3 k € | |
| Equity | 26,2 k € | -22.2% | 33,7 k € | |
| Total assets | 56,0 k € | +5.1% | 53,3 k € | |
| Cash | 5,0 k € | — | ||
| Debts | 29,8 k € | +51.9% | 19,6 k € | |
| Staff | — | 0 | ||
Private limited company · Diepenbeek · incorporated on 20/08/2024
Private limited company loss-making in the latest fiscal year.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Sealantium Medical Belgium is a Private limited company incorporated in 2024. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Diepenbeek.